Recent studies explore how time-restricted eating may reduce protein aggregation in Huntington’s disease, with implications for Alzheimer’s and Parkinson’s treatment. Emerging resear...
A 12-week clinical trial explores time-restricted eating’s potential to improve mitochondrial function and cognitive performance in early-stage Huntington’s disease. Groundbreaking researc...
A groundbreaking clinical trial investigates time-restricted eating for Huntington’s disease, exploring neuroprotective mechanisms and practical implementation for patients. The TREAT-HD trial e...
A 12-week clinical trial evaluates the safety and feasibility of time-restricted eating in early-stage Huntington’s disease, focusing on metabolic outcomes and disease biomarkers. A new clinical...
